GSK, Sanofi, and Haleon Shares Slump on Zantac Litigation Concerns GSK, Sanofi, and Haleon Shares Slump on Zantac Litigation Concerns

Shares in GSK, Sanofi, and Haleon fell sharply on Thursday, following declines earlier this week, amid growing investor concerns about U.S. litigation focused on a heartburn drug that contained a probable carcinogen.Reuters Health Information
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news